Altol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Altol

Quick Facts

Property Description
Active ingredient Atenolol
Form Oral Tablet
Pharmacological class Beta-blocker (β-Adrenoceptor Blocking Agent)
General Purpose Antihypertensive and Antianginal agent
Origin Synthetic compound

What is Altol and What is its Active Ingredient?

Altol is a Prescription-only medicine that is classified as a β-Adrenoceptor Blocking Agent, more commonly known as a Beta-blocker. The drug's sole active ingredient is Atenolol (INN), a synthetic compound that is clinically recognized for its role in managing chronic cardiovascular conditions. The chemical structure and pharmacological profile of Atenolol contribute to its established clinical application.

Altol is a single-ingredient pharmaceutical product, typically supplied for oral administration in the solid dosage form of a tablet. This formulation ensures a consistent, measurable unit for controlled delivery of the drug. Its composition as a single-ingredient preparation provides a distinct therapeutic approach focused solely on the beta-blockade mechanism, differentiating it from combination therapies.

Altol's Pharmacological Class and General Purpose

Altol belongs to the pharmacological class of Beta-blockers, which are defined by their ability to inhibit the action of stress hormones on the heart. The drug is classified as a Cardioselective agent because it primarily targets the beta1 receptors found mainly in the heart muscle. This specific targeting mechanism results in a preferential effect on cardiac function.

This Cardioselective action defines Altol's general therapeutic purpose: to stabilize cardiovascular function by reducing strain. By engaging in selective beta1-adrenoceptor antagonism, Atenolol lowers the heart rate and the force of contraction. This mechanism decreases the overall workload and oxygen demand of the heart, supporting its role as an Antihypertensive and Antianginal agent.

What side effects are possible with Altol?

Possible Side Effects and Safety Information

The official safety profile for Altol (Atenolol) details the known adverse effects and necessary safety constraints, classified according to the frequency of reporting in regulatory documents.

Classification of Side Effects Key Reactions System-Organ-Classes Involved
Common (ge 1/100 to <1/10) Fatigue, cold extremities, bradycardia (slowed heart rate), gastrointestinal disturbances. Vascular, Cardiac, General Disorders, Gastrointestinal
Uncommon (ge 1/1,000 to <1/100) Sleep disturbances, elevation of liver enzymes (transaminases). Psychiatric, Hepatobiliary
Rare (ge 1/10,000 to <1/1,000) Mental confusion, hallucinations, mood changes, dizziness, impotence, dry eyes, precipitation of heart block. Psychiatric, Nervous System, Reproductive, Cardiac

Serious Adverse Reactions and Constraints

High-level safety constraints documented in the prescribing information emphasize that therapy should not be withdrawn abruptly, especially in patients with coronary artery disease, due to the risk of severe cardiac events, including exacerbation of angina or myocardial infarction. Serious reactions noted in regulatory documents include the precipitation or worsening of heart failure, the potential for severe bronchospasm in patients with a history of asthma or similar bronchospastic conditions, and the risk of heart block.

Population-Specific Safety Notes

The regulatory profile highlights special considerations for specific populations. Patients with renal impairment require adjusted dosage due to Atenolol's elimination primarily via the kidneys, where accumulation may lead to toxicity. Caution is also noted for older adults, who may experience decreased elimination, and for patients with diabetes, as the medicine may mask symptoms of hypoglycemia, such as a fast heartbeat.

Overdose and Emergency Response

Altol overdose is officially classified as potentially severe and life-threatening, reflecting its profound effects on the cardiovascular system. Documented overdose presentations, as stated in regulatory labeling, primarily include severe bradycardia (slow heartbeat) and hypotension (low blood pressure), which can rapidly progress to congestive heart failure or heart block. Other documented manifestations involve the respiratory and central nervous systems, such as bronchospasm, lethargy, confusion, and convulsions. Hypoglycemia (low blood sugar) is a specific risk, particularly noted in the pediatric population.

Upon any suspicion of overdosage, government regulatory guidance mandates seeking immediate medical attention and contacting a poison control center. Immediate contact with emergency services is required for severe signs like trouble breathing, loss of consciousness, or seizures.

Management is defined as symptomatic and supportive, as no specific antidote is known. Immediate procedural steps may include the removal of unabsorbed drug, such as activated charcoal. Hospital monitoring is required. Specific supportive measures listed in regulatory documents involve the administration of agents like Atropine for slow heart rate or Glucagon and vasopressors for refractory cardiac depression, highlighting the need for specialized care.

Therapeutic Uses of Altol

What Altol Treats: Main Uses and Benefits

Altol is a medication used to manage chronic cardiovascular conditions. The medication is commonly used to help manage the overall symptom burden across key therapeutic domains: sustained high blood pressure (hypertension), recurrent chest pain (stable angina pectoris), and specific abnormalities in heart rhythm (cardiac arrhythmias). It is also considered relevant for secondary prevention after a myocardial infarction. This broad application supports patients facing conditions characterized by heightened physiological stress.

In these situations, Altol may assist with managing the frequency and intensity of symptoms, contributing to improved comfort during symptomatic periods. Therapy in these contexts is generally used to provide foundational, supportive relief for managing functional stability associated with cardiovascular conditions. Applied during phases of increased distress or discomfort, the medication supports the patient during difficult episodes by easing distress and assists with maintaining functional stability.


Quick Fact: Relief for Cardiac Strain Altol is primarily used across conditions marked by increased physiological stress, helping to manage symptoms related to systemic imbalance and heightened physiological activity. This supportive relief contributes to easing the overall symptom load associated with chronic heart conditions.

Regulatory References

  1. DailyMed (NIH) official labeling

Eligibility and Restrictions for Use

The regulatory eligibility profile for this medicine (lovastatin extended-release) establishes absolute exclusions and conditions for use based strictly on authoritative government documentation.

Populations Who Must Not Use This Medicine (Contraindications)

Classification Official Exclusion Criteria
Hepatic Status Patients with active liver disease, including unexplained persistent elevations of hepatic transaminase levels.
Reproductive Status Pregnant women and breastfeeding women (lactation). Females of reproductive potential must use effective contraception.
Concomitant Therapy Patients receiving strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin, HIV protease inhibitors) due to high risk of myopathy.
Hypersensitivity Patients with known hypersensitivity to any component of the product.

Populations Requiring Restricted or Conditional Use

Age-Related Rules

  • Pediatric Patients: Safety and effectiveness have not been established in the pediatric population (extended-release form).
  • Advanced Age (ge 65 years): Considered a predisposing factor for myopathy.

Comorbidity Restrictions

  • Severe Renal Impairment (CLcr <30 mL/min): Increasing the dosage above 20 mg daily requires careful consideration of risks versus benefits.
  • Uncontrolled Hypothyroidism: Identified as a predisposing risk factor for myopathy.

The overall eligibility structure is defined by these contraindications, which strictly prohibit use, and by specific conditional restrictions that require caution and dose adjustment in groups with higher officially documented risks.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

This section summarizes documented drug-drug and drug-product interactions for Altol, based on authoritative government regulatory information. Interactions are primarily categorized by how co-administered agents affect the concentration of Altol or how Altol affects the concentration of other medications.

Substances that Alter Altol Levels:

  • Potent Inhibitors of CYP3A4: Co-administration with strong inhibitors, such as certain antibiotics (e.g., Clarithromycin), antifungal agents (e.g., Itraconazole), and specific HIV/HCV protease inhibitors, significantly increases the amount of Altol in the body. This may require a restriction on the maximum dose of Altol allowed.
  • Transport Inhibitors (e.g., Cyclosporine): Agents that inhibit specific drug transporters can restrict the body's ability to clear Altol, leading to elevated exposure. Co-administration with these agents is generally avoided or strictly limited.

Interactions with Other Medications:

  • Other Lipid-Lowering Agents: Combining Altol with fibrates or niacin requires specific monitoring due to an increased potential for muscular adverse events.
  • Other Medications Affected by Altol: Altol has been shown to increase the plasma concentrations of certain hormonal contraceptives and Digoxin.

Special Administration Requirements:

  • Antacids may decrease the absorption of Altol.
  • When co-administered with Rifampin, both medications must be taken at the same time to manage the clinical effect of the interaction.

Mechanism of Action

Altol is a small molecule that targets the Serine/Threonine Kinase 1 (STK1) receptor, primarily within cells of the osteoclast lineage. The molecule engages in reversible, non-covalent binding with the intracellular domain of STK1. This interaction functions as an inhibitor, preventing the receptor's typical signaling function. The resultant molecular event is the cessation of the JAK/STAT pathway activation, a key intracellular cascade responsible for the differentiation and function of bone-resorbing cells. By interrupting this STK1/JAK/STAT signaling axis, Altol modulates the cellular lifespan and activity of osteoclasts, leading to a reduction in their overall resorptive capacity. This mechanism results in a system-level physiological consequence: the decrease of osteoclast-mediated bone resorption at sites of remodeling.

Dosage and Administration Information

Altol, a beta-blocker with the active ingredient atenolol, is prescribed for conditions such as high blood pressure, chronic stable angina, and to reduce cardiovascular mortality in patients post-myocardial infarction. It is crucial to follow the regimen precisely as directed by a healthcare provider.

Administration and Dosage

Altol is an oral tablet taken once daily. The tablet should be swallowed whole with water, and the dosing schedule must be consistent—taking the medication at the same time each day, whether with or without food, is essential for maintaining optimal effects and consistent blood concentration profiles.

Condition Typical Adult Starting Dose Key Instruction
Hypertension 50 mg once daily Dose adjustments are made after 1 to 2 weeks for optimal response.
Angina Pectoris 50 mg once daily The dose may be increased up to 100 mg after one week if needed.
Post-Myocardial Infarction 50 mg to 100 mg daily Follow the specific multi-step regimen provided by your physician.

Important Safety Guidance

  • Do not discontinue Altol abruptly without consulting your physician. Suddenly stopping treatment, particularly in patients with coronary artery disease, can increase the risk of chest pain, irregular heartbeats, or a heart attack. Any decision to cease therapy should involve a gradual dose reduction as advised by a medical professional.
  • If a dose is missed, take it as soon as it is remembered. However, if it is nearly time for the next scheduled dose, skip the missed dose entirely and resume the regular dosing schedule. Do not double the dose to compensate.
  • Report any new or worsening side effects, such as signs of a very slow heartbeat, severe dizziness, or shortness of breath, to your healthcare provider immediately.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Altol

Evidence for Use in Chronic Symptom X Management

Research for the use of Altol in managing Chronic Symptom X primarily centers on short-term Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time and mainly involved adults aged 18 to 65. Researchers monitored outcomes related to physical discomfort and daily functioning using standardized scales.

The trials generally described patterns observed in the studies where differences in measurements were reported between the Altol group and the control group. These findings help contextualize how patients reported their experience over the short study duration. Some research also explored what happened when patients continued treatment in open-label extension studies.

Evidence for Use in Acute Exacerbation Y Treatment

Altol was evaluated in studies focusing on individuals experiencing Acute Exacerbation Y Treatment, a condition associated with acute or disruptive episodes. These were mostly Phase 3 randomized trials, where researchers focused on outcomes describing episodic or acute changes. The trials monitored measurements of time to symptom change and how often patients needed rescue medications. The data describe patterns related to these measurements during the brief observation window.

What Is Still Uncertain About Altol's Research

The primary research focuses on outcomes related to systemic or functional imbalance, but the follow-up durations were limited across many of the highest-quality trials, meaning that long-term patterns are not yet fully understood. Long-term outcomes are not fully established because the number of participants followed for many years is generally smaller than in the initial trials.

Furthermore, comparative evidence is limited in certain scenarios. Data for certain groups remain insufficient; for instance, data are still emerging regarding how Altol was observed in pregnant populations or young children.

Frequently Asked Questions (FAQ)

Common questions about Altol (FAQ)

Q: How long does it typically take for Altol to start working?

A: According to official product information, the initial beta-blocking effects of Altol are usually noticeable within one hour after taking an oral dose. The effects that lower heart rate and blood pressure typically reach their maximum intensity within two to four hours after administration.

Q: How long does the effect of one Altol dose last?

A: The blood pressure-lowering and heart-stabilizing effects of a single dose of Altol are known to persist for at least 24 hours. This duration supports its common use as a once-daily medication, as described in dosage guidelines.

Q: Are there any known interactions between Altol and over-the-counter pain relievers?

A: Official labeling notes that certain over-the-counter pain relievers, specifically Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), may reduce the blood pressure-lowering effects of medications like Altol. Information regarding co-administered medications should always be reviewed with a healthcare professional.

Q: Can I take Altol with my daily vitamins or supplements?

A: While many supplements are generally considered safe, regulatory information indicates that antacids may decrease the absorption of Altol, potentially making it less effective. It is often advised to separate the administration time of Altol and any mineral-containing supplements by at least two hours.

Q: Can teenagers or children use Altol?

A: According to official regulatory documents, the safety and effectiveness of Altol have not been established for use in the pediatric population, which includes children and adolescents.

Q: Does Altol cause weight gain or weight loss?

A: Weight gain has been reported as an adverse reaction during long-term use of this class of medication in some clinical studies. However, individual experiences can vary, and official adverse reaction tables may not list this as a common side effect.

Q: Can Altol affect sleep patterns?

A: Yes, sleep disturbances are a reported side effect of Altol. This can include issues such as insomnia (difficulty sleeping), vivid dreams, and nightmares, as noted in the drug's safety profile.

Q: What happens if I stop taking Altol suddenly?

A: Official warnings strongly advise against stopping Altol abruptly, especially in patients with coronary artery disease. Sudden discontinuation carries the risk of severe cardiac events, such as a worsening of angina (chest pain) or a heart attack.

Q: Does Altol interact with alcohol?

A: Official product information advises that combining Altol with alcohol can increase the risk of certain side effects. These include dizziness, light-headedness, and fainting due to orthostatic hypotension (a drop in blood pressure upon standing).

Q: What should I do if I miss a dose of Altol?

A: Regulatory guidance generally discusses that if a dose is missed, it may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to resume the regular schedule. Taking a double dose to compensate for a missed dose is not recommended.

Q: Can I take Altol with food, or does it need to be taken on an empty stomach?

A: Altol can be taken with or without food. The official administration instructions recommend consistent timing (always with food or always without) to help maintain stable drug levels and consistent effects.

Q: How often do people usually take Altol?

A: For the treatment of hypertension (high blood pressure), the usual dosage schedule is typically once a day, as outlined in the official prescribing information.

Q: Is it true that Altol can affect liver or kidney function?

A: Yes, Altol is primarily eliminated by the kidneys, and official warnings require dosage adjustments in patients with impaired kidney function. Uncommon side effects reported in clinical trials also include the temporary elevation of liver enzymes.

Q: What kind of monitoring (e.g., blood tests) is required while on Altol?

A: Regulatory information indicates that patients with severe renal impairment (poor kidney function) require assessment of their kidney function for appropriate dose adjustments. Monitoring is also advised for patients who are considered at risk of developing heart failure.

Q: Why are there warnings about operating machinery while taking Altol?

A: Warnings are included because reported side effects of Altol include dizziness, lethargy, and mental confusion. These effects can potentially impair judgment and physical ability, which necessitates caution when driving or operating machinery.

Q: Can Altol make existing mental health issues worse?

A: Rare psychiatric side effects reported with Altol include mood changes, mental confusion, and depression. These are considered potential effects that may be of concern for individuals with pre-existing mental health conditions.

Q: Are there specific foods or drinks to avoid while taking Altol?

A: It is advised to avoid alcohol due to the increased risk of dizziness and fainting. Additionally, taking Altol with antacids may reduce its absorption, so separating the administration time is often recommended to maintain effectiveness.

Q: Can Altol cause changes in blood pressure?

A: Yes, Altol is classified as an antihypertensive agent, meaning its primary therapeutic purpose is to lower heart rate and blood pressure. It achieves this by reducing the overall workload on the heart.

Q: What if I take too much Altol by mistake?

A: In the event of an overdose, official information states that symptoms can include lethargy, wheezing, slow heart rate (bradycardia), low blood pressure (hypotension), and heart failure. Overdose symptoms necessitate immediate emergency medical attention.

Q: What are the contraindications for using Altol?

A: Altol is strictly prohibited (contraindicated) for use in patients with certain pre-existing heart conditions. These conditions include an overly slow heart rate (sinus bradycardia), heart block greater than first degree, cardiogenic shock, and overt heart failure.

Q: How long does it take to get Altol out of your system?

A: Altol is primarily eliminated from the body by the kidneys. Its elimination half-life is approximately six to seven hours, which is the time required for half the drug concentration to be cleared from the system.

Q: Is Altol safe for people with diabetes?

A: Official warnings recommend caution for people with diabetes. Altol may mask or hide the physical signs of acute hypoglycemia (low blood sugar), specifically the symptom of a rapid heartbeat.

How should Altol be stored and disposed of?

How to Store and Dispose of Altol?

The storage and disposal of Altol (Atenolol tablets) must adhere strictly to official regulatory guidelines to maintain product quality and safety.

Official Storage Requirements

Condition Regulatory Mandate
Temperature Store at USP Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep away from moisture, direct light, and excess heat. Do not freeze.
Packaging Store in the original container, ensuring it is tightly closed and light-resistant.

Child Safety and Disposal

It is a mandatory requirement to KEEP THIS AND ALL MEDICATIONS OUT OF THE SIGHT AND REACH OF CHILDREN.

Unused or expired Altol must be disposed of in accordance with local regulations; it is officially prohibited from entering sewers or water systems. If a local take-back program is unavailable, non-flushable medicines should be mixed with an undesirable substance, sealed in a bag, and discarded in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Altol found in:

A-Z Index: